Relationship of a non-cystic fibrosis transmembrane conductance regulator- mediated chloride conductance to organ-level disease in Cftr(-/-) mice by Clarke, L.L. et al.
Proc. Natl. Acad. Sci. USA
Vol. 91, pp. 479-483, January 1994
Medical Sciences
Relationship of a non-cystic fibrosis transmembrane conductance
regulator-mediated chloride conductance to organ-level disease
in Cftr(-/-) mice
(cystic fibrosis/ion transport/airway/pancreas/intestine)
LANE L. CLARKE*t, BARBARA R. GRUBB*, JAMES R. YANKASKAS*, CALVIN U. COTTONt,
ANDREW MCKENZIE*, AND RICHARD C. BOUCHER*§
*Department of Medicine, Pulmonary Division, The University of North Carolina, Chapel Hill, NC 27599-7020; and tDepartment of Pediatrics, Case Western
Reserve University, Cleveland, OH 44106
Communicated by Harley W. Moon, August 27, 1993 (receivedfor review June 18, 1993)
ABSTRACT Although loss of cystic fibrosis transmem-
brane conductance regulator (CFTR)-mediated Cl channel
function is common to all epithelia in cystic fibrosis (CF)
patients, the severity of disease varies in different organs. We
hypothesized that differences in disease severity in CF relate to
the expression of an "alternative" plasma membrane Cl-
conductance. In CF mice [Cftr(-/-); mice homozygous for
Ser-489 to Xaa mutation], which do not express cAMP CFTR-
mediated Cl- secretion, we surveyed organs that exhibit a
range of disease severity for a Ca2+-mediated apical membrane
epithelial Cl- conductance. This alternative conductance (C1-)
was detected in epithelia of organs from CF mice that exhibit
a mild disease phenotype (airway, pancreas) but not in epithelia
with a severe phenotype (small, large intestine). We conclude
that (i) there is an intracellular Ca2+-regulated Cl- conduc-
tance that is molecularly distinct from CFTR; and (u) the level
of expression of this alternative Cl- conductance in the epi-
thelium is an important determinant of the severity of organ-
level disease in CF.
Cystic fibrosis (CF) is caused by mutations in the Cftr gene,
which encodes an epithelial Cl--channel protein (1, 2). The
CF transmembrane conductance regulator (CFTR) Cl- con-
ductance is usually localized to the epithelial cell apical
membrane and is characterized by cAMP regulation and
insensitivity to the distilbene derivative Cl--channel blocker
4,4'-diisothiocyanostilbene (DIDS) (3).
Mutations in the CF gene likely lead to uniform loss of
CFTR protein and/or functions in all affected epithelia in the
body (4). However, major differences exist in the severity of
disease among affected organs (5). These differences may
relate to the expression of alternative, non-CFTR Cl- con-
ductances in the epithelium, which protect the cell from the
loss of the plasma membrane CFTR-mediated Cl- conduc-
tance. It has previously been shown that a Ca2+-mediated
pathway that regulates transepithelial Cl- secretion can be
activated in airway (3, 6) but not intestinal epithelia from CF
patients (3, 7-10), making the Ca2+-regulated Cl- conduc-
tance a candidate "alternative" Cl- conductance. However,
it has been difficult to determine whether this type of Cl-
transport reflects epithelial-specific differences in the regu-
lation of a single Cl- conductance-i.e., CFTR or epithelial-
specific expression of different Cl- conductances (i.e., Ca2+-
mediated vs. CFTR-mediated). The latter hypothesis is fa-
vored by macroscopic electrophysiological studies that have
partitioned the cellular Cl- conductance into separate Ca2+
and cAMP-regulated conductances based on anion selectiv-
ity, agonist additivity, and responses to Cl--channel blockers
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(3, 8). On the other hand, no single-channel data have been
reported establishing that Ca2+ activates a unique non-CFTR
apical membrane Cl- channel in human epithelia.
Recently, the "knockout" of the murine Cftr gene by gene
targeting has provided an animal model that does not express
the CFTR Cl--channel protein (11, 12). Early in life,
Cftr(-/-) mice [mice homozygous for the Ser-489 to Xaa
(S489X) mutation] exhibit severe intestinal disease and little
pulmonary disease, which resembles the progression in these
organs in CF patients, including those with chain-termination
mutations similar to Cftr(-/-) mice (13). In contrast with
humans, these mice exhibit little or no pancreatic disease
(11). Thus, Cftr(-/-) mice provide a unique model to (i) test
whether a Cl- conductance molecularly distinct from CFTR
is expressed in epithelia and (ii) survey the distribution ofthis
non-CFTR (i.e., alternative) conductance in epithelia with a
wide phenotypic range of disease. Paralleling studies in
human tissues (3), the Cl- secretory response to Ca2+-
mobilizing agents, sensitivity to DIDS, and intracellular
microelectrodes were used to detect and quantitate the
non-CFTR Cl- conductance.
MATERIALS AND METHODS
Tissue Culture. Nasal turbinates and trachea were excised
from control [littermate Cftr(+/+) and (+/-) mice)] and
Cftr(-/-) mice after euthanasia. Enzymatically isolated
nasal epithelial cells or tracheal ring explants were placed on
collagen matrices (diameter, 3.0 mm) and cultured in hor-
mone- and serum-supplemented media until confluent as
described (12).
Mouse pancreatic intralobular ducts were cultured using
techniques developed by Githens et al. (14). The pancreatic
ductal cultures became confluent, developed a transepithelial
resistance, and were studied in modified Ussing chambers
14-26 days after plating.
Bioelectric Studies. Ussing chamber studies-airway epi-
thelia. Nasal or tracheal preparations were placed in modified
Ussing chambers, bathed in Krebs bicarbonate Ringer's
solution (KBR), the spontaneous transepithelial voltage (Vj)
and Vt response to current pulses (1-3 ,uA) were recorded,
and equivalent short-circuit current (Ieq) was calculated (12).
To study Cl- secretion, the tissues were treated with
amiloride (100 ,uM) in the luminal bath (15, 16), and the Ieq
responses to apical addition of ionomycin (lono; 5 ,uM) or
UTP (100 ,uM) were measured. For Cl- replacement proto-
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cols, Cl- was removed (replaced with equimolar cyclamate)
for 60 min prior to amiloride (100 AM) treatment and expo-
sure to luminal lono or UTP. For Na+ replacement studies,
the luminal compartment of the tissue was bathed for 5-10
min in 0 mM Na+ Ringer's (replaced with equimolar N-meth-
yl-D-glucamine+) solution containing amiloride (100 ,uM)
prior to lono or UTP addition. Cumulative additions of Iono
(or UTP) and DIDS (300 AM) were performed in KBR-bathed
preparations as described above.
Intracellular microelectrode studies-airway epithelia.
Cultured nasal epithelial preparations from control and
Cftr(-/-) mice were placed in a horizontal Ussing chamber,
treated with amiloride (10 ,uM), and impaled with Cl--
sensitive microelectrodes under open circuit conditions (15).
After basal (amiloride treated) parameters were measured,
responses to lono (5 ,uM, luminal) or UTP (100 ,uM, luminal),
and DIDS (300 ,M, luminal) were recorded during continu-
ous impalements. The apical membrane potential difference
(Va) and Vt were referenced to the apical bath, and the
basolateral membrane potential (Vb = Vt - Va) was refer-
enced to the basolateral bath. Fractional resistance of the
apical membrane (fRa), electrochemical driving force for Cl-
secretion across the apical membrane (DFcl), and Cl- per-
meability of the apical membrane (PC') were calculated as
described (17, 18).
Ussing chamber studies-pancreatic ductal epithelium.
Pancreatic duct cultures were studied under conditions iden-
tical to those for airway epithelia. Tissues were studied twice
on separate days by measuring basal parameters followed by
responses to forskolin (10 ,uM) and lono (5 ,uM, luminal) in
KBR or luminal Cl--free solutions.
Ussing chamber studies-intestinal epithelium. Sections
ofjejunum and cecum were rapidly excised from mice after
euthanasia, mounted intact in Ussing chambers, and studied
under voltage clamp conditions (12). Ion substitution and
cumulative agonist/inhibitor protocols were performed as
described above.
Solutions and drugs. A KBR solution described previously
(15, 16) was used unless otherwise indicated. Amiloride
(Sigma), forskolin (Sigma), lono (Calbiochem), UTP (Boeh-
ringer Mannheim), and DIDS (Aldrich) were added from
fresh stocks.
RESULTS AND DISCUSSION
Airway Epithelia. The Ca2+ ionophore Iono stimulated the
Ieq in tracheal epithelium from a control [Cftr(+/+)] mouse
(Fig. 1A). This response was abolished by DIDS. An identical
response was observed in tracheal epithelia from a Cftr(-/-)
mouse (Fig. 1B). The mean Ieq responses of nasal and
tracheal preparations from Cftr(-/-) and control mice to
maximal concentrations of Iono (5 AM) and DIDS are shown
in Fig. 1 C and D, respectively. In both nasal and tracheal
preparations, lono and UTP (data not shown) were equally
effective at stimulating a DIDS-sensitive Ieq in epithelia from
both groups. The Iono-stimulated 'eq was inhibited by Cl-
substitution (% inhibition; nasal, 99.3% control vs. 100.3%
CF; tracheal, 90.3% control vs. 100.4% CF) but not by
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FIG. 1. Bioelectric responses of control (CFTR) and Cftr(-/-) (CF) murine airway epithelial cultures to agents that raise [Ca3+].
Transepithelial potential difference (Vt) and Vt responses to repetitive current pulses (2 pA) of amiloride pretreated tracheal cultures mounted
in Ussing chambers are shown for CTRL (A) and CF (B) mice. Mean increases in Ieq of amiloride pretreated nasal and tracheal epithelial cultures
from both CTRL and CF mice in response to luminal lono (CTRL, n = 10; CF, n = 7) are shown in C, and sensitivity of the lono-induced 'eq
to DIDS is shown in D. Pre, Ieq ofamiloride pretreated cultures in standard Krebs bicarbonate Ringer's solution (n = 7 in both groups; *, different
from Pre, P < 0.05; t, different from Iono, P < 0.05; paired t test).
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Table 1. Effect of luminal application of Iono on transepithelial and intracellular bioelectric parameters of amiloride-pretreated control
and Cftr(-/-) murine nasal epithelial cultures
Transepithelial parameters Cellular parameters Calculated PC',
Vt, mV Rt, Q cm2 Iq, MA/cm2 Va, mV fRa DFcl, mV x 10-6 cm/sec
Control nasal epithelium
Pre -6.1 t 1.9 350 t 66 -15.6 t 2.7 -36.8 t 4.1 0.70 t 0.05 14.8 t 2.8 4.3
Iono -10.7 t 1.8* 317 t 63* -36.0 t 4.2* -31.5 t 3.4* 0.61 t 0.06* 9.5 t 2.7* 9.8
Cftr(-/-) nasal epithelium
Pre -2.3 t 0.3 235 t 32 -10.4 t 1.2 -25.8 t 7.4 0.75 t 0.8 13.1 t 6.8 2.5
Iono -8.0 t 0.9* 199 t 24* -43.9 t 7.5* -19.4 t 6.9* 0.66 t 0.10* 7.5 t 5.7* 11.1
Values represent means t SEM for seven preparations from four control [Cftr(+/+) and (+/-)] and four Cftr(-/-) mice. Pre values
represent measurements in the presence of amiloride (100 ZM, luminal). Iono values represent changes during the maximal increase in Ieq after
agonist addition.
*P < 0.05 (paired t test of Pre vs. Iono for each group).
luminal Na+ substitution, indicating that the Ieq reflected Cl-
secretion.
Intracellular microelectrode studies were performed to test
whether the Iono-stimulated Cl- secretion in both control
and Cftr(-/-) mouse airway epithelia was mediated by
activation of an apical membrane Cl- conductance. The
Iono-stimulated increase in Ieq in both groups of mice was
associated with a decrease in transepithelial resistance (Rt),
a decrease in fRa, and a depolarization of Va (Table 1), a
pattern of cellular responses consistent with activation of an
apical membrane Cl- conductance (15). Furthermore, DIDS
blocked the lono-activated apical membrane Cl- conduc-
tance as evidenced by hyperpolarization of Va and an in-
crease in fRa (CTRL mice: DIDS, AlVa = 7.2 + 1.3 mV, MRa
=0.12 0.04,n =3;CFmice: DIDS,AVa= 4.3 + 0.9mV,
A





AfRa = 0.08 + 0.03, n = 3). Similar microelectrode, ion
substitution, and DIDS responses were observed for UTP
(data not shown). Thus, the pattern of cellular responses, ion
substitution, and responses to transport inhibitors indicates
that intracellular Ca2+ (Cai2+)-mobilizing agents stimulate Cl-
secretion by the activation ofPcl (Table 1) in both normal and
CF murine airway epithelia.
Comparisons of data from murine airways with previous
findings in human subjects reveal two important species
differences with regard to the physiology of epithelial Cl-
secretion. First, as indexed by the ratio of maximal Cl-
secretory currents induced by the cAMP/CFTR-mediated
and Ca2+-mediated pathways, the Ca2+-regulated pathway is
dominant in the mouse [AJeq Ca2+ = 27.3 + 6.4 uA/cm2 (Fig.
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FIG. 2. Bioelectric responses of freshly excised jejunal and cecal preparations to agents that raise [Cai ]. (A) ISC responses and I response
to repetitive voltage pulses of a cecal section from a control [Cftr(+/+)] mouse after cumulative additions of lono (5 ,uM, luminal), DIDS (300
,uM, luminal), and bumetanide (BUMET; 100 pM, basolateral). (B) ISC response of a cecal preparation from a Cftr(-/-) mouse to lono (5 ,uM,
luminal). (C and D) Mean IC responses ofjejunal and cecal preparations from control and CF mice during perfusion with KBR (PRE) to lono
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humans the current ratio of the two pathways is about equal
[AIhc (short-circuit current) Ca21 = 20.0 + 4.1 ,tA/cm2 vs.
Alhc cAMP = 24.1 ± 5.9 puA/cm2 (6)]. Second, the CF murine
nasal epithelium exhibits a basal non-CFTR-mediated C1-
permeability that is substantially larger than human CF nasal
epithelium [CF mouse basal (amiloride pretreated) Pcl = 2.5
x 10-6 cm/sec (Table 1) vs. CF human basal (amiloride
pretreated) Pcl = 0.2-0.7 x 10-6 cm/sec (17, 18)].
Gastrointestinal Epithelia. The responses to Iono and be-
thanechol, an agent that raises Ca+' in intestinal cells via an
inositol trisphosphate-dependent mechanism (19), were
tested in excised jejunal and cecal tissue from Cftr(-/-) and
control mice. lono stimulated an increase in the short-circuit
current (ISC) of the cecum from a control [Cftr(+/+)] mouse
(Fig. 2A). However, in contrast to airway epithelia, the
lono-stimulated ISC in the control intestine was not blocked by
DIDS but was sensitive to the loop diuretic bumetanide. The
DIDS insensitivity of the Cl- current is consistent with
speculations that Ca[+ mobilization induces intestinal Cl-
secretion by activation of basolateral membrane K+ channels
that yields cellular hyperpolarization and an increased driv-























not stimulate the ISc in cecum from a Cftr(-/-) mouse but
instead produced a small reduction of the resting current (Fig.
2B), consistent with Caj!+-induced cation (K+) secretion (21,
22).
The tabulated responses of Cftr(-/-) versus control mice
for jejunal and cecal regions show that lono stimulates ISC in
jejunal and cecal tissues from control but not Cftr(-/-) mice
(Fig. 2C). Bethanacol induced comparable results (data not
shown). The identification of the Iono-stimulated ISC as a Cl-
secretory current in control murinejejunal and cecal epithelia
was established by ion substitution protocols in which AlJc
was shown to be inhibited by bilateral Cl- substitution (121%
and 100% inhibition, jejunum and cecum, respectively) but
not luminal Na+ substitution. Furthermore, the lono-induced
Cl- secretory current was not blocked by DIDS but was
inhibited by bumetanide (Fig. 2D).
Pancreatic Epithelia. The findings in the Cftr(-/-) airway
and intestinal epithelia are consistent with the hypothesis that
a Ca2+-mediated apical membrane Cl- conductance protects
an epithelium from the early onset ofCF disease (23). To test
this hypothesis further, we initiated studies to identify the
conductances mediating Cl- secretion in the murine pancre-
atic ductal epithelium. As shown in Fig. 3A, forskolin stim-
ulates a small increase in 'eq only in control mice, whereas
lono is effective in both control and Cftr(-/-) mice. The
summary data revealed that the Caj1+-induced response is
-3-fold larger than the cAMP response in control mice, and
the absolute magnitude of Iono response may be even greater
in Cftr(-/-) mice (Fig. 3B). Reversal ofthe sequence ofdrug
additions yielded similar results (data not shown). To test
whether both agonists stimulated anion secretion via activa-
tion of an apical membrane anion conductance, Cl- was
removed from the luminal bath to generate a large electro-
chemical gradient for Cl- efflux. The responses to cAMP and
CaF+ were greatly amplified (% increase: forskolin, 434;
ionomycin, 490), consistent with activation of Cl- conduc-
tance by both agonists. As a final test to discriminate between
CFTR-mediated and Ca2+-regulated Cl- secretory paths, the
sensitivity of stimulated currents to DIDS was measured. The
CaF'-stimulated, but not forskolin-stimulated, IS was inhib-
ited by DIDS (% inhibition = 94 ± 17). Thus, in murine
pancreatic ductal epithelium, anion secretion occurs predom-












FIG. 3. Bioelectric responses ofcultured murine pancreatic ducts
to forskolin (10 uM) or lono (5 ,uM). (A) Tracings from control and
Cftr(-/-) epithelia. Transepithelial Vt and Vt responses to current
pulses (1-3 uA) are depicted for cultures bathed in symmetric KBR
solutions. (B) Mean changes in Ieq in response to forskolin (10 AM)
or lono (5 ,uM) for control and CF epithelia bathed in KBR.
FIG. 4. Relationship between relative magnitudes of cAMP
(CFTR) and alternative Cl- conductances in normal animals, in-
dexed by Cl- secretory rates (Ic,), and organ disease in Cftr(-/-)
mice. Disease severity reflects pathology findings reported previ-
ously (11). Data describing relative effectiveness of cAMP- and
Ca?'-mediated Cl- conductances are from this work and a previous
report (12).
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cAMP-regulated CFTR conductance, consistent with the
hypothesis that this conductance protects this organ from
Cftr disruption in CF mice.
Conclusions. The C1- secretory response of Cftr(-/-)
airway epithelia to Iono and UTP establishes that this epi-
thelium expresses a Caf+-activated, DIDS-sensitive apical
membrane Cl- conductance that is molecularly distinct from
CFTR. This conductance also appears to be expressed in
airway and pancreatic ductal epithelium under basal condi-
tions in both normal and Cftr(-/-) mice. In contrast, the
alternative Cl- conductance is not detectable in either normal
or Cftr(-/-) intestinal epithelia.
The pathogenesis of CF is complex and a variety of
intrinsic-e.g., type of Cftr mutation-and extrinsic factors
greatly influence the rate and severity of organ disease. We
analyzed relationships between the alternative Cl- conduc-
tance and organ disease in the CF mouse based on data
reported here and previously (11, 12) to test whether this C1-
pathway is also an important variable in CF pathogenesis.
Fig. 4 shows organ pathology, defined as mild to severe, and
the relative magnitude of the CF1'R (cAMP) and alternative
(CaF'-mediated) conductances, as indexed by regulated C1-
secretion rates. A direct relationship is evident between the
level of expression of the Ca+' (alternative)-regulated con-
ductance and protection of the organ from Cftr disruption.
Finally, if the presence of an alternative Cl- conductance
protects an organ from CFTR dysfunction/absence, three
implications result. First, unless the alternative Cl- channel
has intracellular functions similar to those postulated for
CFTR (24), then only the plasma membrane Cl- conductance
dysfunction ofCFTR in epithelium relates directly to the rate
of organ level pathogenesis. Second, the relative expression
of the alternative conductance may contribute to the heter-
ogeneity of the pulmonary phenotype of patients genetically
homozygous for the common CF mutation-e.g., AF508.
Third, pharmacologic intervention directed at activating the
alternative Cl- conductance in the airways-e.g., inhaled
UTP (25)-should slow the progression of CF lung disease.
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